The Effect of L-Carnitine supplementation administration rout on the prognosis of patients

Phase 3

Recruiting

• Conditions: Patients admitted to the intensive care unit.; Follow-up examination after unspecified treatment for other conditions; Z09.9

• Registration Number: IRCT20170903036041N4
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 135

Inclusion Criteria

Patients admitted to the Intensive Care Unit
At least 17 years old

Exclusion Criteria

History of taking L-carnitine supplements in the last month
Taking corticosteroids and NSAIDs
Severe cardiovascular diseases
Pregnancy
Breastfeeding

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
C-Reactive Protein. Timepoint: The beginning of the study, the third and seventh days after the intervention. Method of measurement: Blood test.;Erythrocyte Sedimentation Rate. Timepoint: The beginning of the study, the third and seventh days after the intervention. Method of measurement: Blood test.;Fasting Blood Sugar. Timepoint: The beginning of the study, the third and seventh days after the intervention. Method of measurement: Blood test.;Insulin. Timepoint: The beginning of the study, the third and seventh days after the intervention. Method of measurement: Blood test.

Secondary Outcome Measures

Name	Time	Method
Cholesterol. Timepoint: The beginning of the study, the third and seventh days after the intervention. Method of measurement: Blood test.;Triglyceride. Timepoint: The beginning of the study, the third and seventh days after the intervention. Method of measurement: Blood test.;Low-density lipoprotein. Timepoint: The beginning of the study, the third and seventh days after the intervention. Method of measurement: Blood test.;High-density lipoprotein. Timepoint: The beginning of the study, the third and seventh days after the intervention. Method of measurement: Blood test.;SOFA score. Timepoint: The beginning and end of the study. Method of measurement: SOFA checklist.;APACHE II score. Timepoint: The beginning and end of the study. Method of measurement: APACHE II score.;Nutrition score. Timepoint: The beginning and end of the study. Method of measurement: NUTRIC score.;Length of stay. Timepoint: Hospitalization days. Method of measurement: Count the number of days.